These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21238979)

  • 1. Low Apgar scores and risk of childhood attention deficit hyperactivity disorder.
    Li J; Olsen J; Vestergaard M; Obel C
    J Pediatr; 2011 May; 158(5):775-9. PubMed ID: 21238979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The duration of breastfeeding and attention deficit hyperactivity disorder.
    Kadziela-Olech H; Piotrowska-Jastrzebska J
    Rocz Akad Med Bialymst; 2005; 50():302-6. PubMed ID: 16358988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attention-deficit/hyperactivity-related symptoms among children with enterovirus 71 infection of the central nervous system.
    Gau SS; Chang LY; Huang LM; Fan TY; Wu YY; Lin TY
    Pediatrics; 2008 Aug; 122(2):e452-8. PubMed ID: 18606624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral outcome including attention deficit hyperactivity disorder/hyperactivity disorder and minor neurological signs in perinatal high-risk newborns at 4-6 years of age with relation to risk factors.
    Sato M; Aotani H; Hattori R; Funato M
    Pediatr Int; 2004 Jun; 46(3):346-52. PubMed ID: 15151555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre- and perinatal risk factors in adults with attention-deficit/hyperactivity disorder.
    Halmøy A; Klungsøyr K; Skjærven R; Haavik J
    Biol Psychiatry; 2012 Mar; 71(5):474-81. PubMed ID: 22200325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADHD and comorbidity in childhood.
    Spencer TJ
    J Clin Psychiatry; 2006; 67 Suppl 8():27-31. PubMed ID: 16961427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology of attention-deficit/hyperactivity disorder (ADHD): a public health view.
    Rowland AS; Lesesne CA; Abramowitz AJ
    Ment Retard Dev Disabil Res Rev; 2002; 8(3):162-70. PubMed ID: 12216060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attention-deficit/hyperactivity disorder, conduct disorder, and young adult intimate partner violence.
    Fang X; Massetti GM; Ouyang L; Grosse SD; Mercy JA
    Arch Gen Psychiatry; 2010 Nov; 67(11):1179-86. PubMed ID: 21041619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perinatal, maternal, and fetal characteristics of children diagnosed with attention-deficit-hyperactivity disorder: results from a population-based study utilizing the Swedish Medical Birth Register.
    Gustafsson P; Källén K
    Dev Med Child Neurol; 2011 Mar; 53(3):263-8. PubMed ID: 20964677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder.
    Barkley RA
    J Clin Psychiatry; 2002; 63 Suppl 12():10-5. PubMed ID: 12562056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Attention-deficit/hyperactivity disorder and substance abuse].
    Davids E; Gastpar M
    Psychiatr Prax; 2003 May; 30(4):182-6. PubMed ID: 12768521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are pervasive developmental disorders and attention-deficit/hyperactivity disorder distinct disorders?
    Hattori J; Ogino T; Abiru K; Nakano K; Oka M; Ohtsuka Y
    Brain Dev; 2006 Jul; 28(6):371-4. PubMed ID: 16504439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attention deficit hyperactivity disorder, combined type, dysthymic disorder and anxiety disorders: differential patterns of neurodevelopmental deficits.
    Vance A; Arduca Y; Sanders M; Karamitsios M; Hall N; Hetrick S
    Psychiatry Res; 2006 Aug; 143(2-3):213-22. PubMed ID: 16876876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults.
    Kollins SH; McClernon FJ; Fuemmeler BF
    Arch Gen Psychiatry; 2005 Oct; 62(10):1142-7. PubMed ID: 16203959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the child with developmental delay.
    Chi CS
    Acta Paediatr Taiwan; 2005; 46(4):191. PubMed ID: 16381330
    [No Abstract]   [Full Text] [Related]  

  • 16. Predictors, clinical characteristics, and outcome of conduct disorder in girls with attention-deficit/hyperactivity disorder: a longitudinal study.
    Monuteaux MC; Faraone SV; Michelle Gross L; Biederman J
    Psychol Med; 2007 Dec; 37(12):1731-41. PubMed ID: 17451627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apgar scores and long-term risk of epilepsy.
    Sun Y; Vestergaard M; Pedersen CB; Christensen J; Olsen J
    Epidemiology; 2006 May; 17(3):296-301. PubMed ID: 16570027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lowering developmental screening thresholds and raising quality improvement for preterm children.
    Marks K; Hix-Small H; Clark K; Newman J
    Pediatrics; 2009 Jun; 123(6):1516-23. PubMed ID: 19482762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of Apgar scores for developmental outcome in premature infants.
    Behnke M; Eyler FD; Carter RL; Hardt NS; Cruz AC; Resnick MB
    Am J Perinatol; 1989 Jan; 6(1):18-21. PubMed ID: 2462884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of attention deficit-hyperactivity disorder in children with nonmonosymptomatic nocturnal enuresis: a 4-year followup study.
    Baeyens D; Roeyers H; Van Erdeghem S; Hoebeke P; Vande Walle J
    J Urol; 2007 Dec; 178(6):2616-20. PubMed ID: 17945295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.